1. Dandan Wan, Yiliang Yang, Yiyao Liu, Xingli Cun, Man Li, Shanshan Xu, Wei Zhao, Yangyang Xiang, YueQiu, Qianwen Yu, Xian Tang, Zhirong Zhang, Qin He*. Sequential Depletion of Myeloid-derived Suppressor Cells and Tumor Cells with a Dual-pH-Sensitive Conjugated Micelle System for Cancer Chemoimmunotherapy. Journal of Controlled Release,2020, 317, 43-56. IF=7.727
2. Man Li, Mengmeng Li, Yiliang Yang, Yingke Liu, Hanbing Xie, Qianwen Yu, Lifeng Tian, Xian Tang, Kebai Ren, Jianping Li, Zhirong Zhang, Qin He*. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy. Journal of Controlled Release, 2020, 321, 23-35. IF=7.727
3. Yang Long, Zhengze Lu, Shanshan Xu, Man Li, Xuhui Wang, Zhirong Zhang, and Qin He*. Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells. Nano Letters, 2020, 20, 4, 2219-2229. IF=11.238
4. Yashi Wang, Sheng Yin, Lin Mei, Yiliang Yang, Shanshan Xu, Xuan He, Mou Wang, Man Li, Zhirong Zhang, Qin He⁎ A dual receptors-targeting and size-switchable “cluster bomb” co-loading chemotherapeutic and transient receptor potential ankyrin 1 (TRPA-1) inhibitor for treatment of triple negative breast cancer. Journal of Controlled Release,2020, 321, 71-83. IF=7.727
5. Yiliang Yang, Yang Long, Yashi Wang, Kebai Ren, Man Li, Zhirong Zhang, Bing Xiang,⁎, Qin He*. Enhanced anti-tumor and anti-metastasis therapy for triple negative breast cancer by CD44 receptor-targeted hybrid self-delivery micelles. International Journal of Pharmaceutics,2020, 577, 119085 IF=4.213
6. Jianping Li, Man Li, Lifeng Tian, Yue Qiu, Qianwen Yu, Xuhui Wang, Rong Guo, Qin He⁎. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy. International Journal of Pharmaceutics,2020, 578, 119122. IF=4,213
7. Qianwen Yu, Yue Qiu, Jianping Li, Xian Tang, Xuhui Wang, Xingli Cun, Shanshan Xu, Yayuan Liu, Man Li, Zhirong Zhang, Qin He*. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy. Journal of Controlled Release, 2020, 321, 564-575. IF=7.727
8. Xuhui Wang, Sheng Yin, Man Li, Jingdong Rao, Dandan Wan, Yue Qiu, Qianwen Yu, Xiaoxiao Chen, Zhengze Lu, Yang Long, Zhirong Zhang, Qin He*. Autophagy inhibition changes the disposition of non-viral gene carriers during blood-brain barrier penetration and enhances TRAIL-induced apoptosis in brain metastatic tumor. Journal of Controlled Release,2020, 321, 497-508. IF=7.727
9. Xuhui Wang, Man Li, Kebai Ren, Chunyu Xia, Jianping Li, Qianwen Yu, Yue Qiu, Zhengze Lu, Yang Long, Zhirong Zhang* and Qin He. On-Demand Autophagy Cascade Amplification Nanoparticles Precisely Enhanced Oxaliplatin-Induced Cancer Immunotherapy. Advanced materials, 2020, 32, 2002160. IF=27.398
10. Yue Qiu, Kebai Ren, Wei Zhao, Qianwen Yu, Rong Guo, Jiao He, Ling Mei, Jiajing Tang, Shanshan Xu, Jianping Li, Jiaojie Wei, Man Li, Zhirong Zhang, Qin He*. A “dual-guide” bioinspired drug delivery strategy of a macrophage-based carrier against postoperative triple-negative breast cancer recurrence. Journal of Controlled Release,2020, 329, 191-204. IF=7.727
您当前位置： 